nct02637284 bpc-157 A human trial was registered. The results were submitted. Then they disappeared from public view. In 2015, a Phase I, randomized, placebo-controlled clinical trial (NCT02637284) was launched bpc-157 interstitial cystitis pilot study
Description
doi: 10.1182/blood-2017-10-809293 43 BuschLMougiakakosDBttner-HeroldMMllerMJVolmerDABachCet al

The results suggest that DPSC injections were effective for both types of bone defects, but the therapeutic effect was more pronounced in the narrow intrabony defect group (Fig

Some anecdotal reports from athletes and patients who have used BPC-157 claim quicker recovery from sprains and less joint pain which align with what the animal data suggest

Move at least 1 inch from your previous injection location each time
